郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Dual histamine H3R/serotonin 5-HT4R ligands with antiamnesic properties: pharmacophore-based virtual screening and polypharmacology.

期刊：Journal of chemical information and modeling发表年份：2014作者：Alban Lepailleur; Thomas Freret; Stéphane Lemaître; Michel Boulouard; François Dauphin; Antoine Hinschberger; Fabienne Dulin; Aurélien Lesnard; Ronan Bureau; Sylvain Rault
阅读更多 →

药效评价Multiparameter optimization in CNS drug discovery: design of pyrimido[4,5-d]azepines as potent 5-hydroxytryptamine 2C (5-HT₂C) receptor agonists with exquisite functional selectivity over 5-HT₂A and 5-HT₂B receptors.

期刊：Journal of medicinal chemistry发表年份：2014作者：R Ian Storer; Paul E Brennan; Alan D Brown; Peter J Bungay; Kelly M Conlon; Matthew S Corbett; Robert P DePianta; Paul V Fish; Alexander Heifetz; Danny K H Ho; Alan S Jessiman; Gordon McMurray; Cesar Augusto F de Oliveira; Lee R Roberts; James A Root
阅读更多 →

药效评价Discovery of the first potent and orally available agonist of the orphan G-protein-coupled receptor 52.

期刊：Journal of medicinal chemistry发表年份：2014作者：Masaki Setoh; Naoki Ishii; Mitsunori Kono; Yuhei Miyanohana; Eri Shiraishi; Toshiya Harasawa; Hiroyuki Ota; Tomoyuki Odani; Naoyuki Kanzaki; Kazunobu Aoyama; Teruki Hamada; Masakuni Kori
阅读更多 →

药效评价Pharmacologically distinct phenotypes of α1B -adrenoceptors: variation in binding and functional affinities for antagonists.

期刊：British journal of pharmacology发表年份：2014作者：Hatsumi Yoshiki; Junsuke Uwada; Abu Syed Md Anisuzzaman; Hidenori Umada; Ryoji Hayashi; Mie Kainoh; Takayoshi Masuoka; Matomo Nishio; Ikunobu Muramatsu
阅读更多 →